MAR vs PPCB · P/E 32, rev $26.19B vs P/E 0.0, $3.9M cap
Marriott International Inc (MAR) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
Marriott International Inc (MAR) is a lodging company listed on US.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported MAR revenue for 2025-12-31 was $26.19B. Net income was $2.60B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
PPCB does not have a complete income-statement cache yet.
MAR currently screens at market cap $76.70B and trailing P/E 31.9. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the MAR and PPCB stock pages for the full models.
Not investment advice.